retatrutide fda status 2025 The has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have retatrutide side effects clinical trials

It plays several critical roles: Appetite suppression GLP-1 acts on the hypothalamus and brainstem to reduce hunger signals and increase feelings of fullness

Long-term data on sustained weight loss maintenance with continued GLP-1 receptor agonist therapy in post-bariatric populations remains limited, highlighting the need for ongoing research and extended follow-up studies

They also discuss emerging trends in aesthetic and reconstructive eye surgery, regenerative skin treatments, and why long-term maintenance and skin health matter just as much as procedures

Migraines are the second-leading cause of disability worldwide, the above agency states, with symptoms including severe headaches, nausea and sensitivity to light often disrupting daily activities

GLP-1 receptor agonists have moved from niche diabetes therapies to some of the most commonly encountered medications in modern clinical practice